| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Immunovant, Inc. (IMVT) has 8 insiders with recent SEC Form 4 filings, including 7 buys and 3 sells. IMVT is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 1.48M | $43.14M | - | |
| Other | 218.0K | $6.38M | - | |
| Other | 199.7K | $5.84M | - | |
| COO | 175.9K | $5.14M | - | |
| Other | 152.2K | $4.45M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan 7, 2022 | Barnett Eva Renee58 | Chief Financial Officer | Sell | 29,959 | $7.25 | $217,202.75 | -14.8% | -36.0% | +146.8% | |
| Jan 7, 2022 | Salzmann Peter51 | Chief Executive Officer | Sell | 125,158 | $7.25 | $907,395.50 | -17.8% | -36.0% | +146.8% | |
| Jan 5, 2022 | MacIas William L.51 | Chief Medical Officer | Sell | 26,813 | $8.28 | $222,011.64 | -12.0% | -30.4% | +146.4% | |
| Aug 27, 2021 | Hughes Douglas J. | Director | Buy | 18,247 | $8.24 | $150,355.28 | +45.4% | -7.5% | -29.4% | |
| Aug 20, 2021 | Migausky George V | Director | Buy | 7,000 | $7.65 | $53,550.00 | +11.6% | +0.6% | -20.9% | |
| Aug 13, 2021 | Pande Atul74 | Director | Buy | 5,000 | $7.98 | $39,900.00 | +12.4% | +7.5% | -28.7% | |
| Aug 10, 2021 | Fromkin Andrew J.45 | Director | Buy | 5,500 | $7.90 | $43,450.00 | +13.7% | +9.0% | -32.5% | |
| Sep 11, 2020 | Butchko Julia G.46 | Chief Dev. &Tech. Officer | Buy | 5,000 | $38.17 | $190,850.00 | New | - | - | |
| Dec 11, 2019 | Wong Roderick | Chief Executive Officer | Buy | 31,500 | $10.92 | $344,024.10 | +3.6% | - | - | |
| Dec 10, 2019 | Wong Roderick | Chief Executive Officer | Buy | 25,971 | $10.38 | $269,516.65 | +3.1% | - | - |